/ WHAT YOU WILL RECEIVE
Real photographs of your peptides, boxed, lot-labeled, and shipped in plain unmarked packaging from our partner research lab.
More batch photos and lab footage coming soon.
PEPTIDE SEQUENCE · STRUCTURE NOTE
GEPPPGKPADDAGLV (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val)
15-amino-acid pentadecapeptide isolated from a protective protein in human gastric juice. Exceptional pH stability, no disulfide bonds.
⏱ HALF-LIFE · PHARMACOKINETIC PROFILE
Healing pentadecapeptide (gastric origin)
~4 to 6 hours
Short systemic half-life · effects appear cumulative over multi-week protocols.
Healing Peptides · RESEARCH GRADE
BPC-157
10mg · Lyophilized Vial
BPC-157 (Body Protection Compound), 15-amino-acid pentadecapeptide for regenerative research.
UNIT PRICE
$48 USD
≈ CA$67
Reconstitution required
This compound requires bacteriostatic water for reconstitution. Don't forget to add a 10mL vial of BAC water to your order, available in Lab Supplies.
HOW LONG WILL IT LAST YOU?
Enter your research protocol and vial quantity — see exactly how many weeks your order covers.
Each 10mg vial lasts
20 days
Your 10mg vial lasts
20days
≈ 20 days · 20 doses per vial
FOR RESEARCH USE ONLY
Not for human consumption. Intended for laboratory and in-vitro research applications./ RESEARCH DOSSIER
Everything we know
about BPC-157.
Direct from the research literature. Every section is sourced from peer-reviewed peptide studies and clearly labelled when effects come from animal or cell-line models.
/ 01 · WHAT WE KNOW
The background.
BPC-157 is a synthetic 15-amino-acid peptide derived from a protective protein found in human gastric juice. It is one of the most well-studied research peptides, with extensive preclinical literature on tissue regeneration, vascular repair, and gut-protective signaling.
/ 02 · WHAT IT DOES FOR YOU
What researchers study it for.
Researchers use BPC-157 to investigate accelerated tissue repair, tendon and ligament healing, vascular regeneration via VEGF upregulation, and gastrointestinal mucosa protection. Notable for its exceptional pH stability and broad effect across organ systems in animal models.
RESEARCH HIGHLIGHTS · published animal & cell-model studies
- ▸Tendon and ligament repair acceleration in animal models
- ▸GI mucosal protection / repair in ulcer-induced research models
- ▸Neurological recovery markers in TBI research
- ▸Fibroblast migration and collagen synthesis enhancement in vitro
Sourced from peer-reviewed research literature. Effects described are from animal & cell-line models unless otherwise noted. For research use only.
/ 03 · HOW IT WORKS
Mechanism of action.
Biological pathways identified in the research literature for BPC-157.
Upregulates VEGFR2 expression → angiogenesis pathway activation
Modulates nitric oxide system, implicated in vascular and cytoprotective effects
Interacts with growth-hormone receptor pathway in fibroblast tissue
Stabilizes serotonergic and dopaminergic systems in CNS research models
/ 04 · OVERVIEW & CLASSIFICATION
Classification.
Body Protection Compound 157, synthetic 15-residue partial sequence isolated from human gastric juice.
TYPE
Synthetic pentadecapeptide
DERIVATION
Solid-phase peptide synthesis. Stable in gastric juice (unique for peptides).
STRUCTURE
GEPPPGKPADDAGLV, 15 amino acids, no disulfide bonds, exceptional pH stability.
/ 05 · PHARMACOLOGICAL PROFILE
Pharmacology.
HALF-LIFE
Short systemic half-life (~30 minutes)
ABSORPTION
Subcutaneous, oral (gastric-stable), and intramuscular routes researched
DISTRIBUTION
Wide tissue distribution, particularly in injured/inflamed tissue
/ 06 · DOSAGE & RECONSTITUTION
Research dosing protocols.
/ 07 · PAIRS WELL WITH
Researched stacks.
Compounds explored alongside BPC-157 in the published literature.
TB-500 (sold separately)
BPC-157 + TB-500 protocols target complementary repair pathways, BPC-157 drives localized angiogenesis and collagen organization at the injury site, while TB-500 enhances systemic actin sequestration and progenitor cell migration. Researchers running combination protocols typically dose them separately.
/ 08 · SAFETY PROFILE
Safety notes.
- ▸Generally well-tolerated across research literature
- ▸Mild injection-site reactions reported occasionally
- ▸Long-term safety data limited, extended-protocol research ongoing
Research use only · not for human consumption · always consult published literature before designing any research protocol.